| Literature DB >> 33134999 |
Kyle N Kunze1, Robert A Burnett2, Elaine K Lee3, Jonathan P Rasio2, Shane J Nho2.
Abstract
PURPOSE: To determine factors predictive of patients who are at risk for being lost to follow-up after hip arthroscopy for femoroacetabular impingement syndrome (FAIS).Entities:
Year: 2020 PMID: 33134999 PMCID: PMC7588627 DOI: 10.1016/j.asmr.2020.07.007
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Baseline Patient Demographics and Potential Risk Factors Between Patients Who Completed Follow-Up and Those Who Were Lost to Follow-Up at 2 Years After Hip Arthroscopy for Femoroacetabular Impingement Syndrome
| Risk Factor | Completed Follow-up (n = 1667) | Lost to follow-up (n = 446) | |
|---|---|---|---|
| Age, y | 32.6 ± 12.6 | 30.6 ± 11.9 | |
| BMI kg/m2 | 25.1 ± 5.1 | 25.7 ± 5.3 | |
| Race | |||
| White/Caucasian | 1505 (90.3%) | 390 (87.4%) | |
| African American | 35 (2.1%) | 27 (6.0%) | |
| Other non-white/Caucasian | 127 (7.6%) | 29 (6.6%) | |
| Sex | |||
| Male | 537 (32.2%) | 170 (38.1%) | |
| Female | 1130 (67.8%) | 276 (61.9%) | |
| Smoking status | .07 | ||
| No | 1207 (90.1%) | 321 (86.8%) | |
| Yes | 132 (9.9%) | 52 (13.2%) | |
| Alcohol use | |||
| No | 273 (16.4%) | 83 (18.7%) | .052 |
| Yes | 1394 (83.6%) | 363 (81.3%) | |
| Hypertension | .82 | ||
| No | 1212 (90.6%) | 396 (90.2%) | |
| Yes | 126 (9.4%) | 43 (9.8%) | |
| Diabetes (type I or II) | .06 | ||
| No | 1294 (96.9%) | 416 (95.0%) | |
| Yes | 41 (3.1%) | 22 (5.0%) | |
| Autoimmune disease | .61 | ||
| No | 1630 (97.8%) | 433 (97.3%) | |
| Yes | 37 (2.2%) | 13 (2.7%) | |
| Drug allergy | .20 | ||
| No | 820 (67.4%) | 263 (68.7%) | |
| Yes | 396 (32.6%) | 120 (31.3%) | |
| Psychiatric illness | .68 | ||
| No | 1081 (85.0%) | 357 (85.8%) | |
| Yes | 191 (15.0%) | 59 (14.2%) | |
| Previous orthopaedic surgeries | .43 | ||
| No | 1312 (78.7%) | 359 (80.6%) | |
| Yes | 355 (21.3%) | 87 (19.4%) | |
| Chronic hip pain | |||
| No | 967 (80.8%) | 257 (67.6%) | |
| Yes | 230 (19.2%) | 123 (32.4%) | |
| Worker’s compensation | .11 | ||
| No | 1303 (95.7%) | 441 (93.8%) | |
| Yes | 59 (4.3%) | 29 (6.2%) | |
| Sports participation | .81 | ||
| No | 379 (25.8%) | 113 (25.3%) | |
| Yes | 1063 (74.2%) | 333 (74.7%) | |
| Preoperative outcome | |||
| HOS-ADL | 64.5 ± 18.4 | 64.6 ± 17.7 | .94 |
| HOS-SS | 41.6 ± 23.1 | 40.9 ± 22.8 | .59 |
| mHHS | 58.3 ± 14.5 | 60.0 ± 14.9 | |
| IHOT-12 | 35.5 ± 17.9 | 35.4 ± 17.8 | .97 |
| VAS Pain | 61.9 ± 21.4 | 56.1 ± 22.3 | |
| SF-12M | 53.1 ± 10.5 | 52.3 ± 10.4 | .21 |
| SF-12P | 36.4 ± 9.8 | 35.5 ± 8.8 | .15 |
| Phone number provided | |||
| No | 890 (53.4%) | 279 (62.5%) | |
| Yes | 777 (46.6%) | 167 (37.5%) | |
| E-mail address provided | .12 | ||
| No | 22 (1.5%) | 25 (5.8%) | |
| Yes | 1435 (98.5%) | 403 (94.2%) | |
| Revision surgery | .081 | ||
| No | 1278 (92.8%) | 306 (92.4%) | |
| Yes | 90 (7.2%) | 25 (7.6%) | |
| Preoperative PT | .11 | ||
| No | 337 (25.5%) | 83 (21.5%) | |
| Yes | 987 (74.5%) | 304 (78.5%) | |
| Preoperative CSI | |||
| No | 506 (38.6%) | 188 (48.1%) | |
| Yes | 806 (61.4%) | 203 (51.9%) |
NOTE. Values are presented as means ± standard deviation or frequencies and percentages. Frequencies and percentages are representative of relative proportion of patients in cases in which all data were not available.
Differences were compared using independent t tests or χ2 independence testing.
Bolded P values indicate statistically significant differences at the P < .05 level.
BMI, body mass index; CSI, corticosteroid injection; HOS-ADL, hip outcome score–activities of daily living; HOS-SS, hip outcome score–sports subscale; IHOT-12, international hip outcome tool–12 component questionnaire; mHHS, modified Harris hip score; PT, physical therapy; SF-12M, short-form 12 component questionnaire for mental health; SF-12P, short-form 12 component questionnaire for physical health; VAS, visual analog scale.
LASSO-Selected Variables and Deviance Values for the 3 Models
| Cross-validation | Minimum BIC | Adaptive | |
|---|---|---|---|
| Variables included | |||
| Sex | x | x | x |
| Age | x | ||
| BMI | x | ||
| Race | x | x | x |
| Smoking | x | x | x |
| Drug allergy | x | ||
| Psychiatric illness | x | ||
| Chronic pain | x | ||
| Worker’s compensation | x | ||
| Sports participation | x | ||
| HOS-SS | x | ||
| mHHS | x | x | |
| IHOT-12 | x | x | x |
| Phone number | x | x | |
| Email address | x | ||
| CSI use | x | ||
| Revision surgery | x | ||
| PT | x | ||
| Deviance | |||
| Training sample | 0.91 | 1.55 | 0.91 |
| Testing sample | 1.88 | 1.45 | 1.85 |
NOTE. “X” indicates inclusion and estimation of variable within each respective model.
BIC, Bayes information criteria; BMI, body mass index; CSI, corticosteroid injection; HOS-SS, hip outcome score – sports subscale; IHOT-12, International Hip Outcome Tool 12-component questionnaire; mHHS, modified Harris hip Score; LASSO, least absolute shrinkage and selection operator; PT, physical therapy.
Statistically Significant Predictors of Loss to Follow-Up at 2 Years After Hip Arthroscopy for Femoroacetabular Impingement Syndrome Identified by a Machine-Learning Algorithm
| Predictor of Loss to Follow-up | Odds Ratio | 95% Confidence Interval | ||
|---|---|---|---|---|
| Lower Bound | Upper Bound | |||
| Sex | ||||
| Female | Reference | |||
| Male | 1.82 | 1.07 | 3.13 | .028 |
| Race | ||||
| White/Caucasian | Reference | |||
| African American | 2.41 | 1.63 | 7.17 | .013 |
| Other non-white/Caucasian | 1.42 | 1.10 | 4.65 | .042 |
| Smoking | ||||
| Non-/past smokers | Reference | |||
| Current smokers | 1.07 | 1.04 | 1.12 | .021 |
| Phone Number | ||||
| Provided | Reference | |||
| Did not provide | 1.78 | 1.14 | 3.21 | .032 |
| Preoperative mHHS | 1.05 | 1.02 | 1.08 | .014 |
| Preoperative IHOT-12 | 1.03 | 1.01 | 1.05 | .004 |
NOTE. Loss of follow-up defined as failure to provide any patient-reported outcome measure at the 2-year postoperative time point.
IHOT-12, International Hip Outcome Tool 12-item component questionnaire; mHHS, modified Harris Hip Score.
Fig 1Receiver operator curve generated by discriminatory analysis for the logistic regression model.